EyePoint, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
EyePoint, Inc. (EYPT) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $4.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-05
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $3.99M.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $571.00K, a 88.52% decline year-over-year.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $6.23M, a 23.39% decline year-over-year.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$3.06M.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $4.68M, a 18.39% decline from fiscal 2024.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $5.73M, a 277.29% increase from fiscal 2023.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.52M, a 26.79% increase from fiscal 2022.
- EyePoint, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.20M, a 85.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.56M 10-Q · filed 2026-08-05 | $10.79M derived: sum of 3 quarters · filed 2026-08-05 | $7.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $571.00K 10-Q · filed 2026-05-07 | $6.80M derived: sum of 2 quarters · filed 2026-05-07 | $3.74M derived: sum of 3 quarters · filed 2026-05-07 | $274.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.17M derived: sum of 2 quarters · filed 2026-03-05 | -$297.00K derived: sum of 3 quarters · filed 2026-08-05 | $4.68M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$6.53M derived: sum of 2 quarters · filed 2026-08-05 | -$1.55M 10-Q · filed 2025-11-06 | $6.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.50M 10-Q · filed 2026-08-05 | $9.64M derived: sum of 3 quarters · filed 2026-08-05 | $3.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $4.97M 10-Q · filed 2026-05-07 | $13.11M derived: sum of 2 quarters · filed 2026-05-07 | $7.07M derived: sum of 3 quarters · filed 2026-05-07 | $12.13M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.10M derived: sum of 2 quarters · filed 2026-03-05 | $7.16M derived: sum of 3 quarters · filed 2026-03-05 | $5.73M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$6.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$972.00K derived: sum of 2 quarters · filed 2025-11-06 | -$2.40M 10-Q · filed 2025-11-06 | -$1.67M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.64M 10-Q · filed 2025-08-07 | $4.36M derived: sum of 3 quarters · filed 2025-08-07 | $1.48M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.43M 10-Q · filed 2025-05-08 | -$702.00K derived: sum of 2 quarters · filed 2025-05-08 | -$3.59M derived: sum of 3 quarters · filed 2025-05-08 | $2.36M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$2.16M derived: sum of 2 quarters · filed 2025-03-06 | $3.79M derived: sum of 3 quarters · filed 2025-03-06 | $1.52M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.06M derived: sum of 2 quarters · filed 2024-11-07 | $791.00K 10-Q · filed 2024-11-07 | $308.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.68M 10-Q · filed 2024-08-08 | $3.20M derived: sum of 3 quarters · filed 2024-08-08 | $4.97M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.27M 10-Q · filed 2024-05-09 | -$2.75M derived: sum of 2 quarters · filed 2024-05-09 | -$979.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.04M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.29M derived: sum of 2 quarters · filed 2024-03-08 | $3.31M derived: sum of 3 quarters · filed 2024-03-08 | $1.20M 10-K · filed 2024-03-08 |
| 2022-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.79M derived: sum of 2 quarters · filed 2023-11-03 | $1.68M 10-Q · filed 2023-11-03 | $5.13M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$90.00K 10-Q · filed 2023-08-04 | $3.36M derived: sum of 3 quarters · filed 2023-08-04 | $7.03M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$2.11M 10-Q · filed 2023-05-04 | $1.34M derived: sum of 2 quarters · filed 2023-05-04 | $5.01M derived: sum of 3 quarters · filed 2023-05-04 | $8.17M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $7.12M derived: sum of 2 quarters · filed 2023-03-10 | $10.27M derived: sum of 3 quarters · filed 2023-03-10 | $8.48M 10-K · filed 2023-03-10 |
| 2021-09-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $6.83M derived: sum of 2 quarters · filed 2022-11-04 | $5.03M 10-Q · filed 2022-11-04 | $6.31M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.35M 10-Q · filed 2022-08-05 | $2.64M derived: sum of 3 quarters · filed 2022-08-05 | $5.57M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$1.80M 10-Q · filed 2022-05-06 | -$515.00K derived: sum of 2 quarters · filed 2022-05-06 | $2.42M derived: sum of 3 quarters · filed 2022-05-06 | $2.02M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $4.21M derived: sum of 2 quarters · filed 2022-03-14 | $3.82M derived: sum of 3 quarters · filed 2022-03-14 | $1.87M 10-K · filed 2022-03-14 |
| 2020-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.53M derived: sum of 2 quarters · filed 2021-11-05 | $589.00K 10-Q · filed 2021-11-05 | $1.70M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | -$398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.34M 10-Q · filed 2021-08-06 | -$1.23M derived: sum of 3 quarters · filed 2021-08-06 | -$1.57M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$1.94M 10-Q · filed 2021-05-05 | -$829.00K derived: sum of 2 quarters · filed 2021-05-05 | -$1.17M derived: sum of 3 quarters · filed 2021-05-05 | $59.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $770.00K derived: sum of 2 quarters · filed 2021-03-12 | $2.00M derived: sum of 3 quarters · filed 2021-03-12 | $4.60M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $888.00K derived: sum of 2 quarters · filed 2020-11-06 | $3.48M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.83M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $2.59M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$204.00K 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.55M derived: sum of 2 quarters · filed 2019-11-07 | $3.42M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.66M 10-Q · filed 2019-08-07 | $1.16M 10-K · filed 2020-03-16 | |
| 2018-03-31 | -$134.00K 10-Q · filed 2019-05-10 | |||
| 2017-06-30 | $304.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |